Effect of Mango on Gut Microbiota and Metabolic Health
Launched by LAVAL UNIVERSITY · Jan 29, 2019
Trial Information
Current as of May 07, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy men and premenopausal women
- • At least one of the following : BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
- • At least one of the following : TG ≥ 1.35 mmol/L or fasting insulinemia ≥ 42 pmol/L
- • Caucasian origin
- Exclusion Criteria:
- • Nicotine use
- • Metabolic disorders or use of medication that may affect parameters measured in the study
- • Use of dietary supplements or natural health product that may affect parameters measured in the study
- • Use of antibiotics in the last 3 months
- • Surgery in the last 3 months or planned during the study timeline
- • Alcohol consumption \>2 drinks/day
- • Weight change \>5% in the last 3 months
- • Mango aversion, allergy or intolerance
- • Dietary restrictions (vegetarian, gluten avoidance...)
- • Berries consumption \>1 serving/day
- • Pregnancy, breastfeeding or pregnancy planned within 3-6 months
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Québec, , Canada
Patients applied
Trial Officials
Charles.Couillard@fsaa.ulaval.ca Couillard, PhD
Principal Investigator
Laval University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials